Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential interaction between clarithromycin and warfarin

M W Recker1, K L Kier

  • 1Lima Memorial Hospital, OH 45804, USA.

The Annals of Pharmacotherapy
|September 20, 1997
PubMed
Summary

A possible drug interaction between clarithromycin and warfarin was observed. Clarithromycin may increase warfarin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An educational intervention about folic acid and healthy pregnancies targeted at college-age women.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2001
Same author

Longing for mercy, requesting death: pharmaceutical care and pharmaceutically assisted death.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1998
Same author

Thrombocytopenia in intensive care patients: a comprehensive analysis of risk factors in 314 patients.

The Annals of pharmacotherapy·1995
Same author

Drug-usage evaluation: traditional versus outcome-based approaches.

Topics in hospital pharmacy management·1991

Area of Science:

  • Pharmacology
  • Drug Interactions
  • Clinical Medicine

Background:

  • Warfarin is a widely used anticoagulant for managing conditions like atrial fibrillation.
  • Patient adherence to warfarin therapy requires careful monitoring of International Normalized Ratios (INRs).
  • Drug interactions can significantly impact warfarin's efficacy and safety profile.

Observation:

  • A patient on stable warfarin therapy experienced a marked increase in INR after initiating clarithromycin for bronchitis.
  • The INR rose to 16.8, necessitating warfarin discontinuation and vitamin K administration.
  • Warfarin dosage adjustments were required upon restarting therapy to maintain therapeutic INR levels.

Findings:

  • Clarithromycin administration coincided with a significant elevation in the patient's INR, suggesting a potential interaction.
  • The mechanism is hypothesized to involve clarithromycin's inhibition of the cytochrome P450 system, affecting warfarin metabolism.
  • This case indicates clarithromycin may potentiate the anticoagulant effect of warfarin.

Implications:

  • Clinicians should exercise caution when prescribing clarithromycin to patients on warfarin therapy.
  • Close INR monitoring is crucial during concurrent administration to prevent excessive anticoagulation and bleeding risks.
  • Dosage adjustments of warfarin may be necessary when co-administered with clarithromycin.

Related Experiment Videos